Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of lithium carbonate in spinocerebellar ataxia type 2
2009-016317-20Phase 2Active
- Sponsor
- University of Naples Federico II
- Start
- Oct 2009
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lithium carbonate in Spinocerebellar Ataxia Type 2 (SCA2), sponsored by University of Naples Federico II. Primary endpoint: Safety and tolerability (serious and non-serious adverse events). Started Oct 2009; status: active.
02
Drugs
lithium carbonate
03
Conditions
Spinocerebellar Ataxia Type 2 (SCA2)
Beyond the preview
Go deeper on 2009-016317-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016317-20.